Bondada Engineering IPO vs Mono Pharmacare IPO

Comparison between Bondada Engineering IPO and Mono Pharmacare IPO.

IPO Details

Bondada Engineering IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Mono Pharmacare IPO is a SME Bookbuilding proposed to list at NSE SME.

Issue Size and Price

The total issue size of Bondada Engineering IPO is up to ₹40.56 Cr whereas the issue size of the Mono Pharmacare IPO is up to ₹14.07 Cr. The final issue price of Bondada Engineering IPO is ₹75.00 per share and of Mono Pharmacare IPO is ₹28.00 per share.

 Bondada Engineering IPOMono Pharmacare IPO
Face Value₹10 per share₹10 per share
Issue Price (Lower)₹26.00 per share
Issue Price (Upper)₹28.00 per share
Issue Price (Final)₹75.00 per share₹28.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Market Lot Size1600 shares4000 shares
Fresh Issue Size54,08,000 shares50,24,000 shares
Fresh Issue Size (Amount)up to ₹40.56 Crup to ₹14.07 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total54,08,000 shares50,24,000 shares
Issue Size Total (Amount)up to ₹40.56 Crup to ₹14.07 Cr

IPO Timetable

Bondada Engineering IPO opens on Aug 18, 2023, while Mono Pharmacare IPO opens on Aug 28, 2023. The closing date of Bondada Engineering IPO and Mono Pharmacare IPO is Aug 22, 2023, and Aug 30, 2023, respectively.

 Bondada Engineering IPOMono Pharmacare IPO
Issue OpenAug 18, 2023Aug 28, 2023
Issue CloseAug 22, 2023Aug 30, 2023
Basis Of Allotment (Tentative)Aug 25, 2023Sep 04, 2023
Initiation of Refunds (Tentative)Aug 28, 2023Sep 05, 2023
Credit of Share (Tentative)Aug 29, 2023Sep 06, 2023
Listing date (Tentative)Aug 30, 2023Sep 07, 2023

Financials & KPIs

Bondada Engineering IPO P/E ratio is 6.56, as compared to Mono Pharmacare IPO P/E ratio of .

 Bondada Engineering IPOMono Pharmacare IPO
Financials

Company Financials (Restated Consolidated)

Period Ended31 Mar 202331 Mar 202231 Mar 2021
Assets251.15157.62170.92
Total Income370.96334.21288.32
Profit After Tax18.2510.149.21
NET Worth78.3857.8947.76
Reserves and Surplus62.4757.0746.94
Total Borrowing84.2338.0346.67
Amount in ₹ Crore

Company Financials (Restated Consolidated)

Period Ended31 Mar 202331 Mar 202231 Mar 202131 Mar 2020
Assets62.5714.3811.228.72
Total Income37.1028.3811.69
Profit After Tax0.350.100.02
NET Worth4.283.702.02
Reserves and Surplus1.32
Total Borrowing6.446.086.33
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)86%81.02%
Promoter Shareholding (Post-Issue)63.33%56.72%
P/E Ratio6.56
Market Cap₹162.02 Cr.₹49.47 Cr.
ROE22.779.01
ROCE35.6310.34
Debt/Equity1.072.92
EPS₹11.43₹1.99
RoNW22.779.01

Shares Offered

In the Bondada Engineering IPO Retail Individual Investors (RII) are offered 27,04,000 shares while in Mono Pharmacare IPO retail investors are offered 27,04,000 shares. Qualified Institutional Buyers (QIB) are offered in Bondada Engineering IPO and 5,00,000 shares in Mono Pharmacare IPO.

 Bondada Engineering IPOMono Pharmacare IPO
Market Maker Reservation2,88,000 shares2,76,000 shares
QIB5,00,000 shares
NII27,04,000 shares22,60,000 shares
RII27,04,000 shares22,64,000 shares
Total54,08,000 shares50,24,000 shares

Bids Received (Subscription)

Bondada Engineering IPO subscribed 107.76x in total, whereas Mono Pharmacare IPO subscribed 13.42x.

 Bondada Engineering IPOMono Pharmacare IPO
QIB (times)10.89x
NII (times)115.46x8.00x
RII (times)100.05x19.40x
Total (times)107.76x13.42x

Compare with others

Compare:

Bondada Engineering IPO Vs Mono Pharmacare IPO